Trade Negotiators Seek Comment on Elimination of Pharmaceutical Import Duties

Over 9,000 pharmaceutical and chemical intermediates enjoy duty free treatment under the customs regime of the United States and other countries that participate in the World Trade Organization Pharmaceutical Agreement. The Office of the U.S. Trade Representative is seeking public comment on the possible expansion of the list of products subject to this reciprocal duty free treatment (comments were due by April 9, 2010).

This Sidley Update was republished by ILO in its Trade & Customs Newsletter.